HOME NGHP REPORTING GHP REPORTING LIEN RESOLUTION CLINICAL TRIALS ABOUT US CONTACT US
Medicare Consul Services
Sponsors have to report under the Medicare, Medicaid, and SCHIP Extension Act of 2007 (MMSEA) their responsibility to make ongoing medical payments related to treatment of study subject injury according to their Clinical Trial Agreement.
For Sites and Institutions, the Clinical Trial Agreement Subject Injury provision can be a potential source of cost reduction or a Medicare compliance issue.
CMS Probes Sponsor Billing Practices
In a joint meeting brokered by Piatt Consulting to discuss reporting, CMS asked pointed questions about leading Pharma’s billing practices
For leading pharmaceutical firms the debate over whether Title 42 U.S.C. 1395y(b)(8) of the Medicare Secondary Payer (MSP) law is applicable to Clinical Trials has ended.
There has been some confusion about when to report -- payment or adverse event.
DON'T BE FINED -- WE KNOW THE RULES
Engage our highly-experienced team to help you meet your Centers for Medicare and Medicaid Services (CMS) Section 111 Mandatory Insurer Reporting requirements.
We minimize your financial risk while assuring compliance
We know clinical trials from
contract to close out
Pharma 15's Agent of Choice
David Piatt formed Medicare Consul Services LLC (MCS), an independent business dedicated to Mandatory Insurer Reporting services and Piatt Claims Resolution LLC to provide Medicare Claims Resolution. He is the former Program Director of the Medicare Secondary Payer Recovery Contract (MSPRC) where he managed Medicare's national recovery ("liens") efforts.